Microalbuminuria screening in patients with hypertension: recommendations for clinical practice
Author:
- 29 October 2007
- journal article
- review article
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 62 (1) , 97-108
Abstract
Correlations between renal and cardiovascular (CV) pathologies in advanced kidney or heart disease are well characterised, but less clearly defined in the early stages. Microalbuminuria, in addition to being an early sign of kidney damage, is often found in patients with essential hypertension, suggesting that it may reflect early vascular abnormalities. Studies have shown that even very low levels of microalbuminuria strongly correlate with CV risk: albumin excretion rates as low as 4.8 microg/min, well below the microalbuminuria thresholds stated in current clinical guidelines, are associated with increased risk of CV and cerebrovascular disease, independent of the presence of other risk factors. Increased microalbuminuria indicates endothelial dysfunction or developing atherosclerosis and predicts end-organ damage, major cardio or cerebrovascular events and death. Available tests for screening microalbuminuria are sensitive, reliable and accessible; current European and US guidelines advocate annual screening in patients with diabetes and wherever possible in non-diabetic patients with hypertension. Early identification of high-risk patients through detection of microalbuminuria allows selection of aggressive treatment to slow disease progression. Antihypertensive agents providing angiotensin II blockade are recommended for the treatment of hypertensive patients with microalbuminuria, regardless of diabetes and/or early or overt nephropathy. Treatment with angiotensin II receptor blockers provides effective reduction of microalbuminuria and blood pressure, and long-term prevention of CV events beyond blood pressure reduction. In addition, pharmacoeconomic studies have shown that these long-term benefits translate into a substantially reduced burden on healthcare resources.Keywords
This publication has 77 references indexed in Scilit:
- Systematic review on urine albumin testing for early detection of diabetic complicationsHealth Technology Assessment, 2005
- Preserving cardiac function in the hypertensive patient: why renal parameters hold the keyEuropean Heart Journal, 2005
- Global burden of hypertension: analysis of worldwide dataThe Lancet, 2005
- Microalbuminuria and cardiovascular riskAmerican Journal of Hypertension, 2004
- Very Low Levels of Microalbuminuria Are Associated With Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and DiabetesCirculation, 2004
- Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE StudyAnnals of Internal Medicine, 2003
- Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertensionJournal of Human Hypertension, 2002
- Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic IndividualsJAMA, 2001
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 1999
- Microalbuminuria in prediction and prevention of diabetic nephropathy in insulin-dependent diabetes mellitus patientsJournal of Diabetes and its Complications, 1995